Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
3 drugs for “Bipolar I Disorder”
Approved 1
- CariprazineAbbVie Inc.Bipolar I Disorder
Phase 3 2
- BXCL501BioXcel Therapeutics, Inc.Bipolar I Disorder · next catalyst 14 Nov 2026
- AzetukalnerXenon Pharmaceuticals Inc.Bipolar I Disorder
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.